Drugs / Ejiao compound
Ejiao compound
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02656225 | Mar 2015 → Jun 2016 | — | The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ejiao compound | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02656225 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Chinese patent medicine” NCT02656225 ↗ |
| Route | Oral | “The participants in experimental group receive Ejiao compound (20ml, twice daily) orally for 4 weeks.” NCT02656225 ↗ |